preload

Press Releases



All Releases
View Summary Talon Therapeutics' Product Candidate Marqibo(R) to be Assessed by Oncologic Drug Advisory Committee (ODAC) on March 21, 2012 With a PDUFA Date of May 13, 2012
Feb 3, 2012
PDF 68.3 KB Add to Briefcase
View Summary Talon Therapeutics Announces $11M Financing
Jan 9, 2012
PDF 22.4 KB Add to Briefcase
View Summary Talon Therapeutics Announces First Patient Enrolled in the Phase 3 OPTIMAL>60 Study of Marqibo(R) in Adult Patients With Newly Diagnosed, Aggressive Non-Hodgkin's Lymphoma
Nov 29, 2011
PDF 23.2 KB Add to Briefcase
View Summary Talon Therapeutics, Inc. Reports Third Quarter 2011 Financial Results
Nov 14, 2011
PDF 36.1 KB Add to Briefcase
View Summary Talon Therapeutics to Host a Conference Call to Report Third Quarter 2011 Financial Results and Business Update on November 15, 2011
Nov 11, 2011
PDF 22.6 KB Add to Briefcase
View Summary Talon Therapeutics' New Drug Application for Marqibo(R) Accepted for Filing by the United States Food and Drug Administration
Sep 27, 2011
PDF 68.6 KB Add to Briefcase
View Summary Talon Therapeutics Receives Special Protocol Assessment Agreement from the Food and Drug Administration for Its Phase 3 Confirmatory Study of Marqibo(R) in Newly Diagnosed Acute Lymphoblastic Leukemia
Aug 29, 2011
PDF 73.7 KB Add to Briefcase
View Summary Talon Therapeutics, Inc. Reports Second Quarter 2011 Financial Results
Aug 15, 2011
PDF 35.3 KB Add to Briefcase
View Summary Talon Therapeutics to Host a Conference Call to Report Second Quarter 2011 Financial Results and Business Update on August 15, 2011
Aug 9, 2011
PDF 23.1 KB Add to Briefcase
View Summary Talon Therapeutics Announces First Patient Enrolled in National Cancer Institute Phase 1 Trial of Marqibo(R) in Children and Adolescents
Jul 20, 2011
PDF 26.0 KB Add to Briefcase
View Summary Talon Therapeutics Submits New Drug Application for Marqibo(R)
Jul 18, 2011
PDF 70.7 KB Add to Briefcase
View Summary Talon Therapeutics Provides NDA Submission Timeline Update for Marqibo(R)
Jun 30, 2011
PDF 25.2 KB Add to Briefcase
View Summary Talon Therapeutics Presents Marqibo(R) Hematopoietic Stem Cell Transplantation (HSCT) "Bridging" Data at American Society of Clinical Oncology 2011 Annual Meeting
Jun 6, 2011
PDF 26.9 KB Add to Briefcase
View Summary Talon Therapeutics, Inc. Reports First Quarter 2011 Financial Results
May 13, 2011
PDF 33.3 KB Add to Briefcase
View Summary Talon Therapeutics to Commence a Phase 3 Study of Marqibo(R) in Adult Patients With Newly Diagnosed Non-Hodgkin's Lymphoma (NHL)
May 10, 2011
PDF 26.8 KB Add to Briefcase
View Summary Talon Therapeutics to Host a Conference Call to Report First Quarter 2011 Financial Results and Business Update on May 13, 2011
May 9, 2011
PDF 22.2 KB Add to Briefcase
View Summary Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2010 Financial Results
Mar 28, 2011
PDF 35.2 KB Add to Briefcase
View Summary Talon Therapeutics to Host a Conference Call to Report Fourth Quarter and Full Year 2010 Results and Business Update on March 28, 2011
Mar 24, 2011
PDF 22.1 KB Add to Briefcase
View Summary Talon Therapeutics to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference
Mar 14, 2011
PDF 24.8 KB Add to Briefcase
View Summary New Patent Issued for Talon Therapeutics' Marqibo(R) Expands Disease Coverage to Include Lymphoma, Leukemia and Myeloma
Mar 10, 2011
PDF 25.9 KB Add to Briefcase
Showing 1-20 of 251 Page: 1 2 3 4 5 ... 13  Next 20
Add to Briefcase = add release to Briefcase

Investors


Stock Information

Ticker TLON  
Exchange BB  
Last Price 0.92  
Change -0.03 3.158%
Volume 8,600
Last Trade Feb 8, 2012 at 10:21 AM
Quotes delayed at least 20 minutes. Information provided by eSignal.

Shareholder Tools


Search IR